Study guide

12.1 Dental and Medical Emergencies in the Dental Office

Integrated National Board Dental Examination INBDE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: INBDE Exam Structure & Test Specifications

1.1 INBDE Format, Administration, Scoring & Retesting 1.2 The Domain of Dentistry: Test Specifications, Item Formats, Patient Boxes & Dental Charts

2 Chapter 2: Foundation Knowledge — Anatomic Sciences & Development

2.1 Gross & Head/Neck Anatomy and Histology 2.2 Oral Embryology, Tooth Development & Eruption 2.3 Genetic, Congenital & Developmental Conditions

3 Chapter 3: Foundation Knowledge — Biochemistry, Physiology & Physical Sciences

3.1 Biochemistry and Systemic Physiology 3.2 Physics & Chemistry of Oral Biology: pH, Diffusion & Demineralization

4 Chapter 4: Foundation Knowledge — Pathology, Microbiology & Immunology

4.1 General & Systemic Pathology 4.2 Microbiology, Immunology, and Infection Pathogenesis

5 Chapter 5: Foundation Knowledge — Pharmacology

5.1 Dental Pharmacology, Local Anesthetics, and Analgesics 5.2 Systemic Medications and Drug Interactions in Dentistry

6 Chapter 6: Foundation Knowledge — Dental Anatomy, Occlusion & Materials

6.1 Tooth Morphology, Anatomy, and Occlusion Biomechanics 6.2 Dental Materials Science, Biomaterials, and Impression Systems

7 Chapter 7: Patient Evaluation & Data Gathering

7.1 Chief Complaint, History Taking & Information from Diverse Sources 7.2 Comprehensive Patient History, Examination, and Medical Risk Assessment 7.3 Vital Signs, ASA Physical Status & Medical Risk Stratification 7.4 Normal Findings vs Significant Deviations Requiring Management

8 Chapter 8: Diagnostic Imaging

8.1 Dental Radiology Physics, Safety, and Imaging Interpretation 8.2 Intraoral Radiographic Technique, Errors & Quality Assurance 8.3 Radiographic Interpretation of Caries, Periapical & Bone Lesions 8.4 Panoramic, CBCT & Selection Criteria for Advanced Imaging

9 Chapter 9: Diagnostic Reasoning & Systemic Assessment

9.1 Diagnostic Testing, Laboratory Values, and Medical Complexities 9.2 Predictive Diagnostic Reasoning & Selecting the Right Diagnostic Test 9.3 Oral–Systemic Interrelationships 9.4 Differential Diagnosis of Orofacial Pain

10 Chapter 10: Oral Pathology & Mucosal Disease

10.1 Benign and Malignant Oral Pathology and Biopsy Protocols 10.2 Managing Oral Mucosal and Osseous Diseases

11 Chapter 11: Treatment Planning, Prognosis & Communication

11.1 Interdisciplinary Treatment Planning Sequencing and Prognosis 11.2 Prognosis Determination & Presenting Treatment Alternatives 11.3 Informed Consent, Refusal & Patient Education 11.4 Patient Attributes, Culture, Social Background & Care Across the Lifespan 11.5 Psychological, Social & Behavioral Principles in Patient Communication 11.6 Evaluating the Outcomes of Comprehensive Dental Care

12 Chapter 12: Medical & Dental Emergencies

12.1 Dental and Medical Emergencies in the Dental Office 12.2 Recognizing and Triaging Dental Emergencies

13 Chapter 13: Caries, Operative & Esthetic Dentistry

13.1 Caries Risk Assessment, Prevention, and Operative Dentistry 13.2 Adhesive Dentistry, Composite/Amalgam Restorations, and Esthetics 13.3 Managing the Esthetic Needs of Patients

14 Chapter 14: Endodontics

14.1 Pulpal Biology, Endodontic Diagnosis, and Emergency Treatment 14.2 Endodontic Therapy, Root Canal Instrumentation, Obturation, and Surgery

15 Chapter 15: Periodontics & Implantology

15.1 Periodontal Pathogenesis, Etiology, and Disease Classification 15.2 Non-Surgical Periodontal Therapy and Maintenance Protocols 15.3 Surgical Periodontics, Mucogingival Procedures, and Regenerative Care 15.4 Dental Implants: Planning, Surgical Placement, and Restorative Options

16 Chapter 16: Prosthodontics & Laboratory Communication

16.1 Fixed Prosthodontics: Crown/Bridge Preparation, Design, and Cementation 16.2 Removable Complete Dentures: Impression, Occlusion, and Delivery 16.3 Removable Partial Dentures: Components, Design, and Frameworks 16.4 Communicating Case Design to the Dental Laboratory

17 Chapter 17: Pain Control, Anesthesia & Oral Surgery

17.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation 17.2 Dentoalveolar Surgery, Tooth Extraction, and Surgical Complications 17.3 Maxillofacial Trauma, Odontogenic Infections, and Complex Surgery

18 Chapter 18: Occlusion, TMD & Orthodontics

18.1 Craniofacial Growth, Development, and Orthodontic Diagnosis/Intervention 18.2 Developmental & Acquired Occlusal Problems 18.3 Temporomandibular Disorders: Diagnosis and Management

19 Chapter 19: Pediatric, Special Care & Vulnerable Patients

19.1 Pediatric Dental Care, Behavior Guidance, and Preventive Services 19.2 Pediatric Restorative Dentistry, Pulpal Therapy, and Dental Trauma 19.3 Special Care Dentistry: Geriatric, Special Needs, and Medically Compromised Patients 19.4 Recognizing, Managing & Reporting Patient Abuse and Neglect 19.5 Recognizing and Managing Substance Use Disorders

20 Chapter 20: Practice Management, Safety Systems & Informatics

20.1 Infection Control Protocols, Sterilization, and OSHA Compliance 20.2 Radiation Safety Guidelines, Dosimetry, and ALARA Principles 20.3 Practice Business Operations, OSHA & Regulatory Compliance 20.4 Catastrophe Preparedness & Practice Continuity Planning 20.5 Managing, Coordinating & Supervising Allied Dental Personnel 20.6 Quality Assurance, Assessment and Improvement 20.7 Dental Informatics, Electronic Records & Emerging Technology 20.8 Scope of Competence, Referral & Professional Self-Assessment

21 Chapter 21: Ethics, Jurisprudence, Evidence & Public Health

21.1 ADA Ethics Code, Jurisprudence, HIPAA, and Professional Conduct 21.2 Evidence-Based Dentistry, Clinical Epidemiology, and Dental Public Health 21.3 Biostatistics, Study Design & Critical Appraisal 21.4 Community Collaboration & Systems of Oral Health Care Delivery 21.5 Emerging Trends and Social/Economic Forces in Oral Health Care 21.6 Prevention, Intervention & Patient Education Strategies

12.1 Dental and Medical Emergencies in the Dental Office

Key Takeaways Explain This Topic AI

Vasovagal syncope is the most common dental office emergency; treatment requires placing the patient in the Trendelenburg position (supine with feet elevated 10-15°), administering 100% oxygen, and monitoring vitals.

Severe anaphylaxis requires immediate intramuscular Epinephrine 0.3 mg (1:1000 concentration) injected into the anterolateral thigh, repeated every 5-15 minutes as needed, followed by IV/IM Diphenhydramine 50 mg.

Local Anesthetic Systemic Toxicity (LAST) presents with early CNS excitation (metallic taste, tinnitus, circumoral numbness, agitation, seizures) followed by CNS/cardiovascular collapse; definitive treatment is Intralipid 20% lipid emulsion therapy.

Angina chest pain is relieved by sublingual Nitroglycerin 0.4 mg (up to 3 doses spaced 5 minutes apart); if chest pain persists, activate EMS immediately and administer chewed Aspirin 325 mg (MONA protocol for suspected MI).

Conscious hypoglycemia is treated with 15-20g fast-acting oral carbohydrates (Rule of 15); unconscious hypoglycemia requires 1 mg Glucagon IM/SC or 50 mL 50% Dextrose (D50W) IV.

Last updated: August 2026

Dental and Medical Emergencies in the Dental Office

Medical emergencies can occur suddenly in the dental setting, often triggered by stress, pain, drug administration, or underlying systemic disease. Dentists must be fully equipped with the knowledge, protocols, and emergency drugs to manage life-threatening situations. On the INBDE, emergency questions test diagnostic recognition, immediate positioning, drug dosages, and sequence of intervention.

1. Vasovagal Syncope (Neurocardiogenic Syncope)

Vasovagal syncope is the most frequent medical emergency in the dental office, accounting for over 50% of all emergency events. It is primarily driven by psychogenic stress, apprehension, or acute pain.

Pathophysiology: Stress induces an initial surge in sympathetic tone followed by a reflex withdrawal of sympathetic tone and hyperactivation of the vagus nerve. This leads to marked peripheral vasodilation, bradycardia, reduced cardiac output, and transient cerebral hypoxia.

Prodromal Symptoms: Warmth, diaphoresis (sweating), paleness, nausea, lightheadedness, weakness, and pupillary dilation.

Immediate Management:

Stop dental treatment immediately.

Place patient in the Trendelenburg position (supine with legs elevated 10-15° above the heart) to restore venous return to the brain. (Contraindicated in pregnant patients in their 3rd trimester—place in left lateral decubitus position to prevent inferior vena cava compression).

Maintain open airway (head-tilt / chin-lift).

Administer 100% oxygen (4-6 L/min via nasal cannula or face mask).

Utilize crushable ammonia spirits vapor inhalant under the nose to stimulate trigeminal sensory nerve endings and respiratory centers.

Monitor vital signs until fully recovered.

2. Anaphylaxis and Acute Allergic Reactions

Anaphylaxis is a severe, life-threatening, systemic Type I IgE-mediated hypersensitivity reaction occurring within minutes of exposure to an allergen (e.g., penicillins, latex, local anesthetics).

Clinical Presentation: Urticaria (hives), angioedema (swelling of lips, tongue, pharynx), bronchospasm (wheezing, dyspnea), profound hypotension, and cardiovascular collapse.

Emergency Management Protocol:

Activate EMS (Call 911 immediately).

Epinephrine 1:1000 (1 mg/mL): Administer 0.3 mg IM (adult dose; 0.15 mg for pediatric patients) into the anterolateral aspect of the middle third of the thigh (vastus lateralis) . Epinephrine acts as a physiological antagonist, causing vasoconstriction (α1), bronchodilation (β2), and decreased vascular permeability (β2).

Repeat Epinephrine: If symptoms do not improve, repeat dose every 5 to 15 minutes .

Supplemental Medications: Administer Diphenhydramine (Benadryl) 50 mg IV/IM (antihistamine) and Hydrocortisone 100 mg IV (corticosteroid to prevent recurrent late-phase reactions).

Airway & Oxygen: Administer 100% oxygen; prepare for emergency cricothyroidotomy if severe upper airway angioedema prevents ventilation.

3. Local Anesthetic Systemic Toxicity (LAST)

LAST occurs when local anesthetic agents enter the central circulation in toxic quantities, caused either by accidental intravascular injection or administration of excessive doses exceeding maximum safe weight-based limits.

Clinical Biphasic Progression:

Early CNS Excitation: Circumoral numbness, metallic taste, auditory tinnitus, dizziness, slurred speech, agitation, tremors, and muscle twitching.

Late CNS Depression & Seizures: Generalized tonic-clonic seizures, coma, respiratory arrest.

Cardiovascular Collapse: Severe bradycardia, ventricular dysrhythmias, hypotension, and cardiac arrest (bupivacaine is particularly cardiotoxic due to slow dissociation from cardiac sodium channels).

Definitive Treatment:

Stop local anesthetic administration immediately; call EMS.

Support airway and ventilation with 100% oxygen.

Administer Intralipid 20% (Lipid Emulsion Therapy) : Acts as a lipid sink, extracting lipophilic local anesthetic molecules from plasma and cardiac tissue. Initial bolus of 1.5 mL/kg IV over 1 minute, followed by continuous infusion.

4. Angina Pectoris vs. Myocardial Infarction (MI)

Chest pain in the dental chair must be immediately evaluated to differentiate reversible myocardial ischemia (angina) from irreversible myocardial necrosis (infarction).

Feature Angina Pectoris Myocardial Infarction (MI)

Pathophysiology Transient coronary artery ischemia without tissue necrosis. Acute coronary artery occlusion resulting in cardiac muscle necrosis.

Pain Characteristics Squeezing, substernal chest pressure radiating to left arm/jaw; lasts < 15-20 min. Severe crushing substernal chest pain, diaphoresis, dyspnea, nausea; lasts > 30 min.

Response to Nitroglycerin Relieved within 2-5 minutes by sublingual Nitroglycerin. Not relieved by sublingual Nitroglycerin.

Management of Chest Pain Protocol:

Stop treatment, sit patient upright.

Administer Nitroglycerin 0.4 mg sublingual (tablet or spray). May repeat every 5 minutes up to a maximum of 3 doses over 15 minutes while monitoring BP.

Contraindication Warning: Never administer Nitroglycerin if the patient has taken a Phosphodiesterase-5 (PDE-5) inhibitor (e.g., sildenafil, tadalafil) within the past 24-48 hours due to the risk of severe, fatal hypotension.

If pain is not relieved after 3 doses of Nitroglycerin or if MI is suspected:

Activate EMS immediately (911).

Administer Aspirin 325 mg (chewed and swallowed for rapid antiplatelet inhibition).

Follow the MONA Protocol (Morphine for pain, Oxygen, Nitroglycerin, Aspirin).

5. Hypoglycemia

Hypoglycemia (blood glucose < 70 mg/dL) is common in diabetic patients who take insulin or oral hypoglycemics but skip meals prior to dental appointments.

Clinical Presentation: Tachycardia, tremor, diaphoresis, anxiety, confusion, irritability, headache, and loss of consciousness.

Conscious Patient (Rule of 15): Administer 15-20 grams of fast-acting oral carbohydrates (e.g., 4 oz orange juice, 3-4 glucose tablets, or commercial glucose gel). Recheck blood glucose in 15 minutes; repeat if still < 70 mg/dL.

Unconscious Patient:

Call EMS.

Do NOT put anything in the mouth (aspiration risk).

Administer Glucagon 1 mg IM or SC (mobilizes liver glycogen stores).

Alternatively, establish IV access and administer 50 mL of 50% Dextrose (D50W) IV push.

6. Acute Seizures and Status Epilepticus

Management of Acute Seizure: Do not restrain the patient; clear the operatory area of sharp instruments and objects; cushion the head; place patient in a lateral decubitus position to prevent airway aspiration of saliva or vomit.

Status Epilepticus: Defined as continuous seizure activity lasting > 5 minutes or recurrent seizures without recovery of consciousness between episodes. This is a medical emergency requiring EMS activation and administration of anticonvulsant therapy: Midazolam 5-10 mg IM/IV or Diazepam 5-10 mg IV.

7. Severe Asthma Attack (Bronchospasm)

Clinical Presentation: Dyspnea, wheezing, coughing, prolonged expiratory phase, and severe anxiety.

Management: Position patient comfortably upright; administer Albuterol Metered-Dose Inhaler (MDI) 2 to 4 puffs (β2-agonist for rapid bronchodilation). Repeat every 20 minutes if needed. Administer 100% oxygen. If refractory and life-threatening, administer Epinephrine 0.3 mg IM.

8. Foreign Body Airway Obstruction / Aspiration

Partial Obstruction with Good Air Exchange: Patient can cough forcefully; encourage coughing, do not interfere with Heimlich maneuver.

Complete Obstruction: Patient cannot speak, cough, or breathe; exhibits universal choking sign (hands clutching neck).

Conscious Patient: Perform Heimlich maneuver (abdominal thrusts) for adults/children; chest thrusts for pregnant or obese patients.

Unconscious Patient: Call EMS, lower to floor, begin CPR starting with chest compressions. Inspect mouth prior to ventilations; do not perform blind finger sweeps.

Aspiration of Dental Object (e.g., crown, endodontic file): If an object is swallowed/aspirated, immediately order a chest and abdominal radiograph to confirm its location (lung vs. stomach) and arrange endoscopic or bronchoscopic retrieval.

Emergency Drug Kit Quick Reference Table

  • Drug Name Primary Indication Standard Adult Dose & Route
  • Epinephrine (1:1000) Anaphylaxis / Severe Bronchospasm 0.3 mg IM (anterolateral thigh)
  • Nitroglycerin Angina Pectoris 0.4 mg sublingual (max 3 doses q5min)
  • Diphenhydramine Mild-Moderate Allergic Reaction 25-50 mg IV / IM / Oral
  • Albuterol Acute Asthma / Bronchospasm 2-4 puffs via MDI inhaler
  • Aspirin Suspected Myocardial Infarction 325 mg chewed and swallowed
  • Glucagon Unconscious Hypoglycemia 1.0 mg IM or SC
  • Intralipid 20% Local Anesthetic Toxicity (LAST) 1.5 mL/kg IV bolus
  • Midazolam Status Epilepticus (> 5 min) 5-10 mg IM or IV